Actinobacillus pleuropneumoniae is a causative agent of porcine pleuropneumonia that is characterized by a fibrinous-hemorrhagic pneumonia and is one of the important bacterial diseases of the respiratory tract of pigs 36 . To date, 15 serotypes are recognized based on an-tigenic diversity of capsular polysaccharide and lipopolysaccharide 3,31 . The disease occurs worldwide and results in serious economic losses to the pig-rearing industry 36 . Prevalent serotypes differ according to country 1, 3, 7, 10, 29, 37, 39 , area and farm.
Introduction
JARQ 42 (4) 2008 H. Ito nostic laboratories can prepare a full set of serotype-specific antisera for serotyping. Furthermore, cross-reactions are often observed among different serotypes in a number of the methods, which prevent accurate typing 12, 22, 23, 24, 25, 28 . The cross-reactions are most likely due to the fact that the polyclonal antisera contain antibodies directed against a variety of antigens including antigens common in A. pleuropneumoniae. In addition, quantitative differences of expressed antigens including both serotype-specific and cross-reacting antigens may affect the results of typing. For these reasons, the development of a new typing method that is not affected by cross-reacting antigens and is useful for prevention of porcine pleuropneumonia is desirable. Therefore, it seems that development of a new typing method based on a particular single antigen and gene would facilitate a more precise typing of A. pleuropneumoniae isolates without influence from the cross-reacting antigens.
Furthermore, if the antigen for typing were a protective antigen of A. pleuropneumoniae, the new typing method could be used as a tool which is directly effective and practical for control and epidemiological analysis of the disease. Especially, to know the antigenic type of protective antigens is important for the appropriate control of porcine pleuropneumonia by vaccination.
This review is part of a series of studies conducted to develop a new typing method based on a particular protective antigen (an outer membrane lipoprotein (OmlA protein)) and its gene (omlA gene) of A. pleuropneumoniae. The usefulness and importance of the OmlA protein for the prevention of A. pleuropneumoniae infection 4, 11, 16 are also manifest by the fact that a recombinant vaccine that contains the OmlA protein as one of protective components is licensed by a vaccine company in North America 2 . The usefulness and importance of the omlA gene for diagnosis of A. pleuropneumoniae infection are also proved by other researchers' reports 5, 8, 13, 14, 32, 33 . Currently a diagnostic kit for detection and typing of A. pleuropneumoniae using the omlA-PCR is marketed by a company in France 8, 32 . Species specificity of a number of the omlA-PCR systems has also been examined, and they have been shown to be species-specific 13,32,33,38 . Cloning and characterization of an outer membrane lipoprotein of an Actinobacillus pleuropneumoniae serotype 5a field isolate 16 The gene encoding an OmlA protein with a molecular mass of 43-kDa was cloned from a Japanese field isolate of Actinobacillus pleuropneumoniae (strain NG-8, serotype 5a) 16 . Immunization of the OmlA protein protected mice from death in a challenge experiment with an A. pleuropneumoniae serotype 5, indicating that OmlA protein is a protective antigen of A. pleuropneumoniae 16 . The protective efficacy of the OmlA protein from A. pleuropneumoniae serotype 5 has been supported by a challenge experiment with pigs by other researchers 4 . Southern blot analysis under low-stringency conditions revealed the presence of a hybridizing sequence in reference strains of serotypes 1, 2, 3, 4, 5a, 5b, 6, 7, 8, 9, 10, 11, and 12 , which are prevalent serotypes in Japan 1,10,37,39 except for serotypes 4 and 10, indicating the presence of allelic variants of omlA gene in the strains of these sero- types 16 . While, Southern blot analysis under high-stringency conditions showed the presence of a sequence highly homologous to the omlA gene of strain NG-8 in reference strains of serotypes 5a, 5b and 10 16 . In addition, a specific serum against OmlA protein of NG-8 detected a homologous protein in the strains of serotypes 5a, 5b and 10 ( Fig. 1A ), suggesting that these serotypes carry an omlA gene and an OmlA protein which are each highly similar among the serotypes. From the data obtained by Western ( Fig. 1A) and Southern blot analysis 16 , the presence of antigenic and genetic diversity of an A. pleuropneumoniae OmlA protein was indicated. In conjunction with a protective efficacy of OmlA protein, general presence of omlA gene in A. pleuropneumoniae and its potential genetic diversity indicate that the OmlA protein and its gene can be used for typing of A. pleuropneumoniae which is directly effective and practical for appropriate control of porcine pleuropneumonia caused by A. pleuropneumoniae.
Genetic diversity of the outer membrane lipoprotein
Nucleotide sequence determination of DNA containing the omlA-like gene in reference strains of A. pleuropneumoniae serotype 1 to 12 (the accession number: AB007572 to AB007584, respectively) revealed that the omlA gene generally exists in A. pleuropneumoniae isolates. The genetic diversity of the omlA gene and the OmlA protein among A. pleuropneumoniae serotypes has been exhibited by the comparison of the gene ( Table 1 ). The positions of the conserved and variable sequences of the omlA gene among A. pleuropneumoniae serotypes could be identified. The nucleotide sequence-based typing of the omlA genes could be used to differentiate A. pleuropneumoniae isolates since the phylogenetic analysis of the nucleotide sequence of omlA genes ( Fig. 2 and Table 2 ) divided A. pleuropneumoniae serotypes into four groups: Group I, serotype 1, 9, 11, and 12; Group II, sero- 5a, 5b and 10 IV 5a, 5b and 10 V 5a, 5b and 10 a): Antigenic typing method developed in this study. Serotype 12 strain cannot be grouped into any group since it did not express any detectable OmlA protein reacting with the antisera prepared in this study. b): Genetic typing method developed in this study. c): Genetic typing method developed in this study. d): A field isolate of A. pleuropneumoniae serotype 3 belongs to Group B (Fig. 1) . While serotype 3 reference strain did not express any detectable OmlA protein reacting with the antisera prepared in this study.
JARQ 42 (4) 2008 H. Ito type 2 and 8; Group III, serotype 3, 4, 6, and 7; and Group IV, serotype 5a, 5b and 10. Since a DNA sequencer and reagents for nucleotide sequence determination are extremely expensive, only a very few veterinary diagnostic laboratories can determine the nucleotide sequence of the omlA gene by themselves. Therefore we have subsequently developed typing methods that are less expensive and can be performed without expensive apparatus in standard veterinary diagnostic laboratories such as Livestock Hygiene Centers in Japan.
Development of typing method based on the antigenic diversity of the outer membrane lipoprotein 16,17
A new serotyping method using Western blot analysis with specific antisera against three antigenically distinct OmlA proteins has been developed 16, 17 . The Western blot analysis using specific antisera against OmlA 5a(NG-8) (Fig. 1A ), OmlA 7 (Fig. 1B) and OmlA 1 (Fig. 1C ) could differentiate reference strains of A. pleuropneumoniae serotypes 1, 2, 4, 5a, 5b, 6, 7, 8, 9, 10, and 11 into three groups: Group A, serotypes 1, 2, 8, 9, and 11; Group B, serotypes 4, 6 and 7; Group C, serotypes 5a, 5b and 10 ( Table 2 ). The reference strain of A. pleuropneumoniae serotype 3 and 12 did not express any detectable OmlA protein ( Fig. 1 and Table 2 ). However, a field isolate of A. pleuropneumoniae serotype 3 could be grouped into Group B (Fig. 1B and Table 2 ). Regarding serotype 12 reference strain, Gerlach et al. 11 observed a different result in Western blot analysis using a specific antiserum against the OmlA protein prepared from serotype 1 strain. They demonstrated that serum against the OmlA protein from a serotype 1 field isolate could detect an immuno-logically homologous protein in serotype 12 reference strain. An ORF (accession numbers: AB007574, AB007584) that has a sequence highly homologous to the omlA 7 and omlA 1 gene is present in serotypes 3 and 12 reference strains stocked in our laboratory, respectively. Hence, serotypes 3 and 12 reference strains used in this study may not produce OmlA protein due to a genetic mutation in the region other than an ORF during repeated passages in laboratories. The three OmlA groups (groups A to C) by Western blot analysis could be distinguished by the nucleotide sequence-based typing ( Table 2 ).
Development of typing method based on the genetic diversity of the outer membrane lipoprotein 30
A new genetic typing method using PCR-RFLP based on genetic diversity of the A. pleuropneumoniae omlA gene was developed 30 . Primers for PCR that amplify all A. pleuropneumoniae strains (5'-CCTAAGGT-GATATGTCCGCA-3' and 5'-GTTGCCGTAGCACCGAT-TACG-3') were selected from a conserved sequence of the omlA of A. pleuropneumoniae. A DNA fragment of approximately 970 bp was amplified from the genomic DNA of 41 Japanese (serotypes 1, 2, 3, 5, and 7) and 1 Canadian (serotype 10) field isolates of A. pleuropneumoniae as well as that of reference strains of A. pleuropneumoniae serotypes 1 to 12 (data not shown), implying that the omlA gene is generally present in A. pleuropneumoniae field isolates as well as reference strains stocked in laboratories. Digestion of the DNA amplified from the reference and field strains with the enzymes VspI yielded specific polymorphic patterns, showing that the omlA genotype is inherent to a given serotype and allowing discrimination of all serotypes into five distinct groups: Group I, serotype 1, 9, 11, and 12; Group II, serotype 2 and 8; Group III, serotype 3, 6 and 7; Group IV, serotype 4; and Group V, serotype 5a, 5b and 10 ( Fig. 3 and Table  2 ). Antigenic type of three OmlA protein groups by Western blot analysis (groups A to C) could be substituted by the PCR-RFLP typing since the antigenic groups could be predicted by the PCR-RFLP grouping ( Table 2) . OmlA serotyping with Western blot analysis may be the best typing method for examination of expression and antigenicity of the OmlA for vaccination. However, the PCR-RFLP typing seems to be more useful for epidemiological study since the PCR-RFLP typing has more superior discriminatory ability than the Western blot analysis. Since the specific antisera for OmlA serotyping are not easily available in veterinary diagnostic laboratories, popularization of the OmlA serotyping may not be easy. On the contrary, the specific antisera are not required for the PCR-RFLP typing and all reagents for the analysis are commercially available. Therefore, standard veterinary diagnostic laboratories equipped with PCR apparatus can easily do the OmlA typing by the PCR-RFLP typing method instead of OmlA serotyping by Western blot analysis.
To date, several PCR-RFLP-based or PCR-based typing methods using allelic variation of the target gene have been proposed for typing of A. pleuropneumoniae. The PCR-RFLP methods using the aroA gene encoding 5-enolpyruvylshikimate-3-phopshate synthase (a key enzyme in the biosynthesis of aromatic amino acids) 15 and apxIV gene encoding an exotoxin (ApxIV) of A. pleuropneumoniae 18 have been developed for typing of the organism. However, it is unknown whether PCR tests for typing of the genes are protective antigens or not. Multiplex PCR tests for typing of the genes involved in the biosynthesis of capsular polysaccharides of A. pleuropneumoniae serotypes 2, 5 and 6 19 and serotypes 1, 2 and 8 34 have also been developed. However, these tests cannot type A. pleuropneumoniae isolates other than serotypes 1, 2, 5, 6, and 8.
Regarding typing methods whose target DNA is a gene for protective antigens of A. pleuropneumoniae other than the omlA gene, PCR assays based on the apx genes encoding toxins (ApxI, ApxII and ApxIII toxins) and a PCR-RFLP test based on the tbpB gene encoding transferring-binding protein (TbpB) which is a component of the iron-uptake system of A. pleuropneumoniae have been developed 6, 9, 14, 35 . Multilocus typing of such genes encoding the protective antigens together with the omlA gene developed in this study would provide more effective and practical information on control and epidemiological analysis of porcine pleuropneumonia.
Consequently, the new genetic typing method of a protective OmlA protein developed in this study can be used as a routine tool which should be directly effective and practical for control and epidemiological analysis of porcine pleuropneumonia in veterinary diagnostic laboratories.
Conclusion
To examine antigenic type of A. pleuropneumoniae protective antigens is important for choice of vaccine. Therefore the genetic and antigenic typing methods of the OmlA protein described in this review used either alone or in combination should be directly effective and practical tools for control and epidemiological analysis of porcine pleuropneumonia caused by A. pleuropneumoniae. 
